valganciclovir has been researched along with Nephrotic-Syndrome* in 3 studies
3 other study(ies) available for valganciclovir and Nephrotic-Syndrome
| Article | Year |
|---|---|
Infantile nephrotic syndrome secondary to cytomegalovirus infection in a 7-month-old girl: resolution with ganciclovir.
Infantile nephrotic syndrome is a rare disorder which is frequently caused by genetic defects. A 7-month-old girl presented with fever, loose stools and anasarca and was diagnosed with nephrotic syndrome. Work-up for a genetic cause was negative. Cytomegalovirus polymerase chain reaction (CMV PCR) was positive and the infant was treated with ganciclovir for 6 weeks, followed by valganciclovir for 10 weeks. All symptoms resolved within 2 weeks of commencing treatment and she attained complete remission within 4 weeks. CMV PCR was negative within 4 weeks of antiviral therapy. At 18 months follow-up she remained well. Appropriate treatment of infantile nephrotic syndrome secondary to CMV should result in recovery. Topics: Antiviral Agents; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Infant; Nephrotic Syndrome; Valganciclovir | 2021 |
Submandibular lymphadenopathy in a child post-renal transplant-"What lies beneath?!": Questions.
Topics: Antibiotic Prophylaxis; Biopsy; Child; Epstein-Barr Virus Infections; Graft Rejection; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lymph Nodes; Lymphadenopathy; Male; Nephrotic Syndrome; Postoperative Complications; Valganciclovir | 2018 |
Pharmacokinetics and dosage individualization of ganciclovir and valganciclovir in an infant with nephrotic syndrome associated with cytomegalovirus infection.
Topics: Antiviral Agents; Creatinine; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Ganciclovir; Humans; Infant; Nephrotic Syndrome; Proteinuria; Treatment Outcome; Urine; Valganciclovir; Viral Load | 2014 |